General Dermatology

Marc Serota, MD, provided clinical pearls to consider for patients on biologics, particularly dupilumab.

Improvements persisted through the 12-week post-treatment follow-up, indicating sustained efficacy even after discontinuation of dupilumab.

Dermatology Times is looking back on the top stories in dermatology from the month of May.

Novartis announced late-breaking data for the BTK inhibitor at the 2024 European Academy of Allergy and Clinical Immunology Congress.

Raj Chovatiya, MD, PhD, reviews the varying degrees of influence of skin barrier disruption, immune dysregulation, and Malassezia yeast in seborrheic dermatitis.

Dermatology Times is recapping our top expert interviews from the month of May.

May is Asian American and Pacific Islander Heritage Month. We review articles from the past month spotlighting dermatologic concerns in this patient population.

Chovatiya was a lead author of the latest seborrheic dermatitis and roflumilast foam review published in the Journal of Clinical and Aesthetic Dermatology.

Social media is fraught with misinformation. Pharmacists play a key role in breaking through the fallacies with facts and education on skin care.

Keep up with the latest headlines in dermatology from the past week, including exposure to UV light and its implications for metabolism, the effects of skin conditions on children, and more.

ICYMI: 5 news headlines that impact the treatment of scars, wounds, melanoma, and other skin conditions impacting veterans and active military personnel.

Regional disparities were highlighted in a study of inpatient dermatology encounters, locations, and providers from 2013 to 2019.

A large amount of studies included in the review centered around the use of botulinum toxin in these indications.

This week’s collection of the latest dermatologic studies includes case reports of onychocytic matricoma, congenital triangular alopecia treated with 5% topical minoxidil, systemic therapy usage in vulvar lichen sclerosus and vulvovaginal lichen planus, and dose escalation of interleukin inhibitors in Japanese patients with psoriasis.

Keep up with the latest headlines in dermatology from the past week, including Johnson & Johnson's acquisition of Proteologix, a review of sunscreen approvals and efficacy, and more.

Scassellati Sforzolini discusses the significance of Galderma’s nemolizumab receiving 4 additional filing acceptances for prurigo nodularis and atopic dermatitis.

It is important dermatologists learn to recognize the clinical findings of dermatophytomas and distinguish them from other onychomycosis subtypes because the recommended treatments differ.

Researchers reviewed research into the medical and toxicological viewpoints of tattooing the skin from the past decade.

The results are both confirmatory and extend the response results from a prior phase 3 trial known as FLASH.

The needs assessment surveyed patients’ stage of treatment, radiation-induced dermatologic adverse effects, and over-the-counter products and home remedies that were used.

In a comparison of pediatric dermatologists versus AI, dermatologists primarily exhibited greater performance.

They are confident prescribing roflumilast to patients with diverse skin and hair characteristics, including those with a history of hair treatments.

This Mother's Day, we are reviewing the interconnected relationships between pregnancy, breastfeeding, skin conditions, and managing dermatoses.

Keep up with the latest headlines in dermatology from the past week, including a California bill proposing banning the sale of anti-aging products to children, collaborative skin cancer awareness efforts, and more.

Researchers explored the risk of SPM in patients of different races with the rare type of tumor of the skin.

Dermatology Times' Spring Editor in Chief, Aaron Farberg, MD, discusses the business strategy known as buy and bill.

Keep up with the latest headlines in dermatology from the past week, including the invention of a groundbreaking method for detecting skin cancer using Terahertz waves, a survey indicative of young people's perceptions of sun exposure, and more.

Our May issue of Dermatology Times spotlights melanoma/skin cancer awareness and more.

May is Mental Health Awareness Month, and Dermatology Times is spotlighting the common relationship between skin conditions and struggles with mental health, quality of life, and well-being.

Learn more about the in-depth topics covered in the April 2024 print issue of Dermatology Times.